The U.S. Food and Drug Administration has authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation, to facilitate muscle re-education and for maintaining or increasing range of motion.
Read more: FDA Authorizes Marketing of Device to Facilitate Muscle Rehabilitation in Stroke Patients